icotine nasal spray for smoking cessation in primary care
Completed
- Conditions
- Tobacco dependenceMental and Behavioural DisordersMental and behavioural disorders due to use of tobacco
- Registration Number
- ISRCTN03150596
- Lead Sponsor
- McNeil AB (Sweden) - formally Pharmacia and Upjohn
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1200
Inclusion Criteria
1. Smokers: smoking for at least 3 years
2. Aged 20 - 60 years, either sex
3. Smokes 15 or more cigarettes a day
4. Motivated to stop
Exclusion Criteria
1. Myocardial infarction within 3 years
2. Chronic nasal disorder
3. Pregnancy, intending pregnancy
4. Breast feeding
5. Current psychiatric care
6. Current use of psychotropic drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Co-verified complete abstinence from smoking for weeks 3 to 12.
- Secondary Outcome Measures
Name Time Method 1. Co-verified complete abstinence from smoking during 12 weeks<br>2. Adverse events